Inflammatory bowel disease in patients with psoriasis treated with interleukin-17 inhibitors

BACKGROUND: Interleukin 17 (IL-17) inhibitors provide an excellent treatment option for patients with psoriasis and psoriatic arthritis, resulting in high levels of efficacy for skin clearance and joint improvement. Safety has also been established in clinical trials for this group of biologic agent...

Descripción completa

Detalles Bibliográficos
Autores principales: Fieldhouse, Keira A, Ukaibe, Samantha, Crowley, Erika L, Khanna, Reena, O’Toole, Ashley, Gooderham, Melinda J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioExcel Publishing Ltd 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7185907/
https://www.ncbi.nlm.nih.gov/pubmed/32362930
http://dx.doi.org/10.7573/dic.2020-2-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7185907/
https://www.ncbi.nlm.nih.gov/pubmed/32362930
http://dx.doi.org/10.7573/dic.2020-2-1

Ejemplares similares